ID   MTMR1_HUMAN             Reviewed;         665 AA.
AC   Q13613; A0A024RC07; Q9UBX6; Q9UEM0; Q9UQD5;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2003, sequence version 4.
DT   15-FEB-2017, entry version 148.
DE   RecName: Full=Myotubularin-related protein 1;
DE   AltName: Full=Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;
DE            EC=3.1.3.95 {ECO:0000269|PubMed:27018598};
DE   AltName: Full=Phosphatidylinositol-3-phosphate phosphatase;
DE            EC=3.1.3.64 {ECO:0000269|PubMed:11733541};
GN   Name=MTMR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING.
RX   PubMed=9828128; DOI=10.1006/geno.1998.5560;
RA   Kioschis P., Wiemann S., Heiss N.S., Francis F., Goetz C., Poustka A.,
RA   Taudien S., Platzer M., Wiehe T., Beckmann G., Weber J., Nordsiek G.,
RA   Rosenthal A.;
RT   "Genomic organization of a 225-kb region in Xq28 containing the gene
RT   for X-linked myotubular myopathy (MTM1) and a related gene (MTMR1).";
RL   Genomics 54:256-266(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4-665.
RC   TISSUE=Brain;
RA   Kioschis P., Wiemann S., Francis F., Goetz C., Poustka A., Taudien S.,
RA   Platzer M., Wiehe T., Beckmann G., Weber J., Nordsiek G.,
RA   Rosenthal A.;
RT   "Ancient genomic duplication within the myotubular myopathy locus
RT   (MTM1) in human Xq28.";
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 114-610.
RX   PubMed=9736772; DOI=10.1093/hmg/7.11.1703;
RA   Laporte J., Blondeau F., Buj-Bello A., Tentler D., Kretz C., Dahl N.,
RA   Mandel J.-L.;
RT   "Characterization of the myotubularin dual specificity phosphatase
RT   gene family from yeast to human.";
RL   Hum. Mol. Genet. 7:1703-1712(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 404-535.
RX   PubMed=8640223; DOI=10.1038/ng0696-175;
RA   Laporte J., Hu L.-J., Kretz C., Mandel J.-L., Kioschis P., Coy J.,
RA   Klauck S.M., Poutska A., Dahl N.;
RT   "A gene mutated in X-linked myotubular myopathy defines a new putative
RT   tyrosine phosphatase family conserved in yeast.";
RL   Nat. Genet. 13:175-182(1996).
RN   [7]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=11733541; DOI=10.1074/jbc.M111087200;
RA   Kim S.A., Taylor G.S., Torgersen K.M., Dixon J.E.;
RT   "Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated
RT   in myotubular myopathy and type 4B Charcot-Marie-Tooth disease.";
RL   J. Biol. Chem. 277:4526-4531(2002).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13] {ECO:0000244|PDB:5C16}
RP   X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) OF 95-665 OF MUTANT SER-438 IN
RP   COMPLEX WITH PHOSPHATE IONS, CATALYTIC ACTIVITY, FUNCTION, SUBUNIT,
RP   DOMAIN, MUTAGENESIS OF CYS-438; ASP-443; ARG-444 AND ARG-484, AND
RP   ACTIVE SITE.
RX   PubMed=27018598; DOI=10.1371/journal.pone.0152611;
RA   Bong S.M., Son K.B., Yang S.W., Park J.W., Cho J.W., Kim K.T., Kim H.,
RA   Kim S.J., Kim Y.J., Lee B.I.;
RT   "Crystal structure of human myotubularin-related protein 1 provides
RT   insight into the structural basis of substrate specificity.";
RL   PLoS ONE 11:E0152611-E0152611(2016).
CC   -!- FUNCTION: Lipid phosphatase that has high specificity for
CC       phosphatidylinositol 3-phosphate and has no activity with
CC       phosphatidylinositol 4-phosphate, phosphatidylinositol (4,5)-
CC       bisphosphate and phosphatidylinositol (3,4,5)-trisphosphate
CC       (PubMed:11733541, PubMed:27018598). Activity with
CC       phosphatidylinositol (3,5)-bisphosphate is controversial; it has
CC       been shown by PubMed:27018598, while PubMed:11733541 find no
CC       activity with this substrate. {ECO:0000269|PubMed:11733541,
CC       ECO:0000269|PubMed:27018598}.
CC   -!- CATALYTIC ACTIVITY: 1-phosphatidyl-1D-myo-inositol 3,5-
CC       bisphosphate + H(2)O = 1-phosphatidyl-1D-myo-inositol 5-phosphate
CC       + phosphate. {ECO:0000269|PubMed:27018598}.
CC   -!- CATALYTIC ACTIVITY: 1-phosphatidyl-1D-myo-inositol 3-phosphate +
CC       H(2)O = 1-phosphatidyl-1D-myo-inositol + phosphate.
CC       {ECO:0000269|PubMed:11733541, ECO:0000269|PubMed:27018598}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:27018598}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q9Z2C4}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q9Z2C4}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q9Z2C4}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q9Z2C4}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q13613-1; Sequence=Displayed;
CC       Name=1A;
CC         IsoId=Q13613-2; Sequence=VSP_005169, VSP_005170;
CC   -!- DOMAIN: The C-terminal region is required for dimerization.
CC       {ECO:0000269|PubMed:27018598}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Non-receptor class myotubularin subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF002223; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471169; EAW99384.1; -; Genomic_DNA.
DR   EMBL; CH471169; EAW99388.1; -; Genomic_DNA.
DR   EMBL; AJ224979; CAA12271.1; -; mRNA.
DR   EMBL; AF057354; AAD40368.1; -; mRNA.
DR   EMBL; U58032; AAC79117.1; -; mRNA.
DR   CCDS; CCDS14695.1; -. [Q13613-1]
DR   RefSeq; NP_001293073.1; NM_001306144.1.
DR   RefSeq; NP_003819.1; NM_003828.3. [Q13613-1]
DR   RefSeq; XP_006724918.1; XM_006724855.3. [Q13613-1]
DR   UniGene; Hs.347187; -.
DR   PDB; 5C16; X-ray; 2.07 A; A/B/C/D=95-665.
DR   PDBsum; 5C16; -.
DR   ProteinModelPortal; Q13613; -.
DR   SMR; Q13613; -.
DR   BioGrid; 114306; 18.
DR   IntAct; Q13613; 1.
DR   STRING; 9606.ENSP00000359417; -.
DR   SwissLipids; SLP:000001136; -.
DR   DEPOD; Q13613; -.
DR   iPTMnet; Q13613; -.
DR   PhosphoSitePlus; Q13613; -.
DR   BioMuta; MTMR1; -.
DR   DMDM; 33112667; -.
DR   MaxQB; Q13613; -.
DR   PaxDb; Q13613; -.
DR   PeptideAtlas; Q13613; -.
DR   PRIDE; Q13613; -.
DR   Ensembl; ENST00000370390; ENSP00000359417; ENSG00000063601. [Q13613-1]
DR   Ensembl; ENST00000485376; ENSP00000434105; ENSG00000063601. [Q13613-2]
DR   GeneID; 8776; -.
DR   KEGG; hsa:8776; -.
DR   UCSC; uc004fei.4; human. [Q13613-1]
DR   CTD; 8776; -.
DR   DisGeNET; 8776; -.
DR   GeneCards; MTMR1; -.
DR   H-InvDB; HIX0017110; -.
DR   HGNC; HGNC:7449; MTMR1.
DR   HPA; HPA002977; -.
DR   HPA; HPA018502; -.
DR   MIM; 300171; gene.
DR   neXtProt; NX_Q13613; -.
DR   OpenTargets; ENSG00000063601; -.
DR   PharmGKB; PA31252; -.
DR   eggNOG; KOG1089; Eukaryota.
DR   eggNOG; ENOG410XPTU; LUCA.
DR   GeneTree; ENSGT00760000118832; -.
DR   HOGENOM; HOG000210598; -.
DR   HOVERGEN; HBG000220; -.
DR   InParanoid; Q13613; -.
DR   KO; K18081; -.
DR   PhylomeDB; Q13613; -.
DR   TreeFam; TF315197; -.
DR   Reactome; R-HSA-1660499; Synthesis of PIPs at the plasma membrane.
DR   ChiTaRS; MTMR1; human.
DR   GeneWiki; MTMR1; -.
DR   GenomeRNAi; 8776; -.
DR   PRO; PR:Q13613; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000063601; -.
DR   CleanEx; HS_MTMR1; -.
DR   ExpressionAtlas; Q13613; baseline and differential.
DR   Genevisible; Q13613; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0052629; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004438; F:phosphatidylinositol-3-phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:0046856; P:phosphatidylinositol dephosphorylation; IDA:UniProtKB.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR004182; GRAM.
DR   InterPro; IPR030587; MTMR1.
DR   InterPro; IPR010569; Myotubularin-like_Pase_dom.
DR   InterPro; IPR030564; Myotubularin_fam.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   PANTHER; PTHR10807; PTHR10807; 1.
DR   PANTHER; PTHR10807:SF99; PTHR10807:SF99; 1.
DR   Pfam; PF02893; GRAM; 1.
DR   Pfam; PF06602; Myotub-related; 1.
DR   SMART; SM00568; GRAM; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS51339; PPASE_MYOTUBULARIN; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell membrane;
KW   Complete proteome; Cytoplasm; Hydrolase; Lipid metabolism; Membrane;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN         1    665       Myotubularin-related protein 1.
FT                                /FTId=PRO_0000094932.
FT   DOMAIN       90    161       GRAM.
FT   DOMAIN      226    601       Myotubularin phosphatase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00669}.
FT   REGION      351    354       Substrate binding.
FT                                {ECO:0000305|PubMed:27018598}.
FT   REGION      376    377       Substrate binding.
FT                                {ECO:0000305|PubMed:27018598}.
FT   REGION      438    444       Substrate binding.
FT                                {ECO:0000305|PubMed:27018598}.
FT   REGION      608    665       Required for dimerization.
FT                                {ECO:0000269|PubMed:27018598}.
FT   COMPBIAS      5     10       Poly-Ala.
FT   COMPBIAS     14     17       Poly-Gly.
FT   COMPBIAS    645    648       Poly-Ser.
FT   ACT_SITE    438    438       Phosphocysteine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10044,
FT                                ECO:0000305|PubMed:27018598}.
FT   BINDING     484    484       Substrate. {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22223895}.
FT   MOD_RES      43     43       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      49     49       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z2C4}.
FT   VAR_SEQ     553    568       DVYTKTISLWSYINSQ -> AWGAGTQRARGSLRSR (in
FT                                isoform 1A). {ECO:0000305}.
FT                                /FTId=VSP_005169.
FT   VAR_SEQ     569    665       Missing (in isoform 1A). {ECO:0000305}.
FT                                /FTId=VSP_005170.
FT   MUTAGEN     438    438       C->S: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:27018598}.
FT   MUTAGEN     443    443       D->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:27018598}.
FT   MUTAGEN     444    444       R->A: Abolishes enzyme activity with
FT                                phosphatidylinositol 3-phosphate. Reduces
FT                                activity with phosphatidylinositol (3,5)-
FT                                bisphosphate.
FT                                {ECO:0000269|PubMed:27018598}.
FT   MUTAGEN     484    484       R->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:27018598}.
FT   CONFLICT    541    541       F -> L (in Ref. 4; CAA12271).
FT                                {ECO:0000305}.
FT   STRAND      106    116       {ECO:0000244|PDB:5C16}.
FT   STRAND      118    120       {ECO:0000244|PDB:5C16}.
FT   STRAND      122    138       {ECO:0000244|PDB:5C16}.
FT   STRAND      145    150       {ECO:0000244|PDB:5C16}.
FT   HELIX       151    153       {ECO:0000244|PDB:5C16}.
FT   STRAND      154    159       {ECO:0000244|PDB:5C16}.
FT   STRAND      172    179       {ECO:0000244|PDB:5C16}.
FT   STRAND      181    185       {ECO:0000244|PDB:5C16}.
FT   HELIX       196    204       {ECO:0000244|PDB:5C16}.
FT   HELIX       206    208       {ECO:0000244|PDB:5C16}.
FT   HELIX       214    217       {ECO:0000244|PDB:5C16}.
FT   HELIX       226    228       {ECO:0000244|PDB:5C16}.
FT   HELIX       232    238       {ECO:0000244|PDB:5C16}.
FT   STRAND      244    249       {ECO:0000244|PDB:5C16}.
FT   TURN        251    254       {ECO:0000244|PDB:5C16}.
FT   STRAND      255    257       {ECO:0000244|PDB:5C16}.
FT   STRAND      265    268       {ECO:0000244|PDB:5C16}.
FT   HELIX       273    281       {ECO:0000244|PDB:5C16}.
FT   HELIX       284    286       {ECO:0000244|PDB:5C16}.
FT   STRAND      290    294       {ECO:0000244|PDB:5C16}.
FT   TURN        296    298       {ECO:0000244|PDB:5C16}.
FT   STRAND      301    305       {ECO:0000244|PDB:5C16}.
FT   TURN        311    314       {ECO:0000244|PDB:5C16}.
FT   HELIX       318    329       {ECO:0000244|PDB:5C16}.
FT   STRAND      337    343       {ECO:0000244|PDB:5C16}.
FT   HELIX       345    353       {ECO:0000244|PDB:5C16}.
FT   TURN        361    363       {ECO:0000244|PDB:5C16}.
FT   STRAND      367    374       {ECO:0000244|PDB:5C16}.
FT   HELIX       377    391       {ECO:0000244|PDB:5C16}.
FT   HELIX       397    399       {ECO:0000244|PDB:5C16}.
FT   HELIX       400    407       {ECO:0000244|PDB:5C16}.
FT   HELIX       409    428       {ECO:0000244|PDB:5C16}.
FT   STRAND      434    437       {ECO:0000244|PDB:5C16}.
FT   STRAND      439    443       {ECO:0000244|PDB:5C16}.
FT   HELIX       444    456       {ECO:0000244|PDB:5C16}.
FT   HELIX       458    461       {ECO:0000244|PDB:5C16}.
FT   HELIX       463    473       {ECO:0000244|PDB:5C16}.
FT   TURN        474    478       {ECO:0000244|PDB:5C16}.
FT   HELIX       481    485       {ECO:0000244|PDB:5C16}.
FT   TURN        486    488       {ECO:0000244|PDB:5C16}.
FT   HELIX       500    514       {ECO:0000244|PDB:5C16}.
FT   TURN        516    518       {ECO:0000244|PDB:5C16}.
FT   HELIX       523    535       {ECO:0000244|PDB:5C16}.
FT   STRAND      543    545       {ECO:0000244|PDB:5C16}.
FT   HELIX       546    551       {ECO:0000244|PDB:5C16}.
FT   HELIX       554    557       {ECO:0000244|PDB:5C16}.
FT   HELIX       561    567       {ECO:0000244|PDB:5C16}.
FT   HELIX       568    572       {ECO:0000244|PDB:5C16}.
FT   HELIX       591    593       {ECO:0000244|PDB:5C16}.
FT   HELIX       598    601       {ECO:0000244|PDB:5C16}.
FT   TURN        602    604       {ECO:0000244|PDB:5C16}.
SQ   SEQUENCE   665 AA;  74678 MW;  12E766859F0DCA75 CRC64;
     MDRPAAAAAA GCEGGGGPNP GPAGGRRPPR AAGGATAGSR QPSVETLDSP TGSHVEWCKQ
     LIAATISSQI SGSVTSENVS RDYKALRDGN KLAQMEEAPL FPGESIKAIV KDVMYICPFM
     GAVSGTLTVT DFKLYFKNVE RDPHFILDVP LGVISRVEKI GAQSHGDNSC GIEIVCKDMR
     NLRLAYKQEE QSKLGIFENL NKHAFPLSNG QALFAFSYKE KFPINGWKVY DPVSEYKRQG
     LPNESWKISK INSNYEFCDT YPAIIVVPTS VKDDDLSKVA AFRAKGRVPV LSWIHPESQA
     TITRCSQPLV GPNDKRCKED EKYLQTIMDA NAQSHKLIIF DARQNSVADT NKTKGGGYES
     ESAYPNAELV FLEIHNIHVM RESLRKLKEI VYPSIDEARW LSNVDGTHWL EYIRMLLAGA
     VRIADKIESG KTSVVVHCSD GWDRTAQLTS LAMLMLDSYY RTIKGFETLV EKEWISFGHR
     FALRVGHGND NHADADRSPI FLQFVDCVWQ MTRQFPSAFE FNELFLITIL DHLYSCLFGT
     FLCNCEQQRF KEDVYTKTIS LWSYINSQLD EFSNPFFVNY ENHVLYPVAS LSHLELWVNY
     YVRWNPRMRP QMPIHQNLKE LLAVRAELQK RVEGLQREVA TRAVSSSSER GSSPSHSATS
     VHTSV
//
